Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 2
2014 1
2015 5
2016 3
2017 4
2018 5
2019 5
2020 6
2021 22
2022 31
2023 28
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Precision Phenotyping for Curating Research Cohorts of Patients with Post-Acute Sequelae of COVID-19 (PASC) as a Diagnosis of Exclusion.
Azhir A, Hügel J, Tian J, Cheng J, Bassett IV, Bell DS, Bernstam EV, Farhat MR, Henderson DW, Lau ES, Morris M, Semenov YR, Triant VA, Visweswaran S, Strasser ZH, Klann JG, Murphy SN, Estiri H. Azhir A, et al. Among authors: semenov yr. medRxiv [Preprint]. 2024 Apr 16:2024.04.13.24305771. doi: 10.1101/2024.04.13.24305771. medRxiv. 2024. PMID: 38699316 Free PMC article. Preprint.
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Chen ST, et al. Among authors: semenov yr. J Immunother Cancer. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675. J Immunother Cancer. 2024. PMID: 38599660 Free PMC article.
Cancer Type and Histology Influence Cutaneous Immunotherapy Toxicities: A Multi-Institutional Cohort Study.
Wan G, Khattab S, Leung BW, Zhang S, Nguyen N, Tran M, Lin C, Chang C, Alexander N, Jairath R, Phillipps J, Tang K, Rajeh A, Zubiri L, Chen ST, Demehri S, Yu KH, Gusev A, Kwatra SG, LeBoeuf NR, Reynolds KL, Semenov YR. Wan G, et al. Among authors: semenov yr. Br J Dermatol. 2024 Feb 15:ljae053. doi: 10.1093/bjd/ljae053. Online ahead of print. Br J Dermatol. 2024. PMID: 38366637
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study.
Reardon RM, Perlman KL, Asdourian MS, Shah N, Jacoby TV, Thompson LL, Reynolds KL, Semenov YR, Chen ST. Reardon RM, et al. Among authors: semenov yr. J Am Acad Dermatol. 2024 Feb 9:S0190-9622(24)00309-8. doi: 10.1016/j.jaad.2024.01.070. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38341147 No abstract available.
Timing of cutaneous immune-related adverse events impacts survival in patients with cancer treated with immune-checkpoint inhibitors: A multi-institutional cohort study.
Rashdan H, Zhang S, Wan G, Nguyen N, Roster K, Rajeh A, Tang K, Chen W, Moseley C, Chen S, LeBoeuf N, Semenov YR. Rashdan H, et al. Among authors: semenov yr. J Am Acad Dermatol. 2024 May;90(5):1080-1083. doi: 10.1016/j.jaad.2024.01.038. Epub 2024 Jan 28. J Am Acad Dermatol. 2024. PMID: 38290617 No abstract available.
99 results